GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of telehealth is the most under-discussed thing in c/progresspics — 44 comments in the full submission. View in context.
2.1k
c/compounding·submitted 12 months ago by u/priya_palacios

telehealth is the most under-discussed thing in c/progresspics

Discussionbranch of 10 comments

Week 68 update. 19kg down from the start, early fullness basically gone since about week 25. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with early fullness. The part that surprised me is how much of this is…

Read the full submission and all 44 comments →

This branch

10 comments, started 11 months ago
u/camila_sandvik89 points·11 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/priya_palaciosOP56 points·11 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/sofia_nascimento27 points·11 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/bilal_osei23 points·11 months ago

state board rules differ, say which state

replysharereportpermalink
u/tobias_vukovic18 points·11 months ago

Not to be pedantic but shortage list and telehealth are being used interchangeably and they are not interchangeable in real life.

replysharereportpermalink
u/jonas_eriksen31 points·11 months ago

Did they tell you their API source or dodge the question?

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/rafael_ostergaard25 points·11 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/ferran_mensah-23 points·11 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/ahmed_okafor28 points·11 months ago·edited

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/incretin_ivypharmacology68 points·11 months ago

The telehealth + compounding combo cost telehealth plus 18% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.